Navigation Links
Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
Date:9/16/2008

CAMBRIDGE, Mass., Sept. 16 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced today that Dr. Joseph Kovalchin will make a poster presentation titled "Evidence of Specific T-cell Priming from the First-in-Man Single Ascending Dose Study of Peptide Copolymer PI-2301 for the Treatment of Multiple Sclerosis " on Thursday, September 18th from 3:30 - 5:00 p.m. in Exhibit Hall 220C, at the Palais Des Congres de Montreal, Canada at the World Congress on Treatment and Research in Multiple Sclerosis. The Congress is expected to attract over 3,500 participants from around the globe -- clinicians, clinical researchers, and basic scientists. This will be the largest single gathering of MS clinicians and researchers in 2008.

PI-2301 is currently in a Phase Ib multiple-ascending dose, double-blind, placebo-controlled randomized study in subjects with multiple sclerosis. Following establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009.

PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva Pharmaceuticals). PI-2301 has been designed to be more efficacious and more convenient (weekly versus daily dosing) than Copaxone for the treatment of multiple sclerosis. PI-2301 works through immune modulation by enhancing the regulatory response of the immune system and thereby controlling the pathogenic autoimmune response observed in some diseases. In a Phase I single ascending dose, double blind placebo controlled randomized study, all doses of PI-2301 were safe and well tolerated, and no serious adverse events were observed. Pharmacodynamic assays demonstrated evidence of immune exposure consistent with the pharmacologic mechanism of action for PI-2301, and dose-dependent pharmacokinetics was observed.

PI-2301 has been optimized using P
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Peptimmune Announces First Close of Series D Private Financing
2. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
3. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
4. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference
5. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
6. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference
8. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
10. Volcano Presentation at Thomas Weisel Conference to Be Webcast
11. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., SPRINGFIELD, Ill., Dec. 1 Pra...to announce that it was recently awarded two statu...nt on Nov. 13 in New York City. The CLIO Healthcar...tion in the healthcare advertising industry and is...,s most recognized awards competitions for adverti...
(Date:12/1/2009)... Congruent Software agrees to migra...project accounting clients) to Synergy Business So... Seattle, WA (PRWEB) December 1, 2009...has acquired the Microsoft Dynamics SL practice of...ology provider. The move was necessary due to a ch...
(Date:12/1/2009)..., INDIANAPOLIS and NORTH VANCOUVER, British Colum...nces LLC, a wholly owned subsidiary of The Dow Che...nces, Inc. today announced the signing of a resear...reement provides Dow AgroSciences with access to A...technology on an exclusive basis in major food cro...
(Date:12/1/2009)..., ATLANTA, Dec. 1 Geo...ompany"), an Atlanta-based, biopharmaceutical comp...by HIV-1 (Human Immunodeficiency Virus) and other ... World AIDS Day. ,, "Today is the 21st World AI...ost their fight with the HIV/AIDS pandemic, we rem...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
...h 17 (Nasdaq: SIAL ) -- Sigma-,Aldrich Corporati...8 Annual,Business Review on Wednesday, March 19, 2...ocated at 2909 Laclede, St. Louis, Mo. 63103, The... 12:30 p.m. CDT,and will also be webcast over the ....com ., About Sigma-Aldrich: Sigma-Aldrich is a l...
...., March 17 VION,PHARMACEUTICALS, INC. (Nasdaq: ...fourth quarter and year-end of 2007., The Company...r share,for the year ended December 31, 2007, comp...r share, for 2006. Weighted-average common shares,...and December 31, 2006,were 6.7 million and 6.6 mil...
..., March 17 Medarex, Inc.,(Nasdaq: MEDX ) announc...al,abstracts are expected to be the subject of ora... the American Association for Cancer Research (AAC...- "Dendritic and T cell functions in patients with...r treated with GVAX immunotherapy for prostate ...
Other Biology Technology:Vion Reports 2007 Fourth Quarter and Year-End Results 2Vion Reports 2007 Fourth Quarter and Year-End Results 3Vion Reports 2007 Fourth Quarter and Year-End Results 4Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research 2Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research 3
(Date:12/1/2009)...LLE, Fla. Hit-and-run attacks by sharks can be so...rits by the unique chomp they put on their victims...and shark expert. , In a method analogous to ana...ntifications by precisely comparing shark bites to...d George Burgess, director of the International Sh...
(Date:12/1/2009)...LAND, Wash. -- Time-lapsed video of individual bre... in the life of a cell: a protein that cycles betw...s give researchers a more complete view of the int...ow, events that go awry in cancer and are targets ...elps cells respond to growth factors, travels back...
(Date:12/1/2009)...ss, like a bad cold, can spread among groups of pe...niversity of California-San Diego and Harvard show...tudy that has been following health conditions for... lonely people tend to share their loneliness with...isconnected people moves to the fringes of social ...
Breaking Biology News(10 mins):New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Loneliness can be contagious 2Loneliness can be contagious 3Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program 3 p m Tuesday October 27 14442 1Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program 3 p m Tuesday October 27 14442 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 1The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 3ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 1ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 2ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 3ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 4
...ears after intense selective logging stopped in th...k, the red-tailed guenon (Cercophithecus ascanius)...ce, scientists report in a new study, changed the ...ehavioral changes and opening the door for multipl...on three primate species, collecting 1,076 fecal s...
...us (Miscanthus x giganteus), a hybrid grass that c...fuel source for the future, researchers at the Uni...ephen P. Long, a professor of crop sciences and of...in, Ireland, where the British Association for the...stival of Science Sept. 3-10. , Closer to home, t...
...ears after intense selective logging stopped in th...k, the red-tailed guenon (Cercophithecus ascanius)...ce, scientists report in a new study, changed the ...ehavioral changes and opening the door for multipl...on three primate species, collecting 1,076 fecal s...
Other Biology News:Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 3Hybrid grass may prove to be valuable fuel source 2Hybrid grass may prove to be valuable fuel source 3Hybrid grass may prove to be valuable fuel source 4Logging changed ecological balance for monkeys, damaged health 2Logging changed ecological balance for monkeys, damaged health 3
Horseradish Peroxidase (HRP) Conjugation Kit For labeling Antigens/Antibodies (Reaction Time 2 hr) from Alpha Diagnostic International Inc
...l-time PCR detection system uses a fixed array of ...two photomultiplier tubes for 2-color detection (5...ilt on an DNA Engine thermal cycler, which include...he thermal cycler, 96-well sample block, optical t...
...een apparatus is used to screen blots of mini form... 40 different antibodies or sera without having to...a base plate, 2 separate, detachable sample templa..., and gaskets and clamps that secure the blots to ...
... detection of SYBR Green I or FAM in the first cha...annel including TET, HEX, VIC, and TAMRA for a m...ic discrimination. DNA Engine thermal cycler offer...ient feature permits simultaneous incubation at 12...
Biology Products: